Deciphering temporal antifungal dynamics of a rare actinomycete via integrated omics.

All biosynthetic gene clusters in Saccharomonospora xinjiangensis XJ-54 are transcriptionally active and exhibit growth-phase-dependent expression, leading to antifungal metabolite production.

• Why it matters: Understanding the biosynthetic potential of rare actinomycetes is crucial for discovering sustainable antifungal agents, as most natural product research has focused on well-studied microbes, leaving many untapped resources unexplored.
• What they did: The study integrated genomic, transcriptomic, and metabolomic analyses of XJ-54, revealing growth-phase-dependent gene expression and metabolite shifts, and identified active antifungal compounds through bioactivity-guided fractionation.
• The result: This work demonstrates that coordinated biosynthetic programs produce antifungal metabolites, providing a framework for optimizing cultivation and prioritizing gene clusters, thereby accelerating natural product discovery for crop protection.